Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Rexer

Showing results (1-10 of 106) with videos related to

Pageof 11
Sort By:
Der Urologe. Ausg. A|February 18, 2011
[AH-10/04 - international study on testicular cancer: randomized phase III study 1xBEP in comparison to 2xBEP for patients with non-seminomatous testicular cancer in clinical stage I (high risk)]H Rexer
Der Urologe. Ausg. A|September 3, 2010
[Second line AUO study AB35/09 of metastasized urothelial cell carcinoma]H Rexer
Der Urologe. Ausg. A|April 8, 2011
[Adjuvant AUO study of renal cell carcinoma after nephrectomy: randomized, double-blind, placebo-controlled phase III study (PROTECT - AN 30/10) to investigate the effectiveness and safety of pazopanib as adjuvant therapy in patients with localized or local advanced renal cell carcinoma after nephrectomy]H Rexer
Der Urologe. Ausg. A|March 23, 2007
[Annual report on study AB25/02-"LEA"]H Rexer
Der Urologe. Ausg. A|June 29, 2007
[New treatment approach to hormone-refractory prostate carcinoma]H Rexer
Der Urologe. Ausg. A|March 29, 2005
[Use of zoledronic acid for high risk prostate cancer patients]H Rexer
Der Urologe. Ausg. A|April 28, 2011
[Study to castrate-resistant prostate cancer: AUO study AP 60/10]H Rexer
Der Urologe. Ausg. A|September 5, 2015
[Study on therapy of metastasized or locally advanced urothelial cancer: A phase III randomized clinical trial of pembrolizumab (MK-3475) versus paclitaxel, docetaxel or vinflunine in subjects with recurrent or progressive metastatic urothelial cancer (Keynote 045) - AP 48/15 der AUO]H Rexer
Der Urologe. Ausg. A|January 28, 2006
[Active studies of the Working Association for Urological Oncology (AUO) in 2006]H Rexer
Der Urologe. Ausg. A|March 19, 2015
[Study on the treatment of nonmuscle invasive bladder cancer: A phase III efficacy study for intravesical instillation of mistletoe extract in superficial bladder cancer (TIM) AB 40/11 of the AUO]H Rexer,
Pageof 11

Showing results (1-10 of 106) with videos related to

Sort By:
Pageof 11
Der Urologe. Ausg. A|February 18, 2011
[AH-10/04 - international study on testicular cancer: randomized phase III study 1xBEP in comparison to 2xBEP for patients with non-seminomatous testicular cancer in clinical stage I (high risk)]H Rexer
Der Urologe. Ausg. A|September 3, 2010
[Second line AUO study AB35/09 of metastasized urothelial cell carcinoma]H Rexer
Der Urologe. Ausg. A|April 8, 2011
[Adjuvant AUO study of renal cell carcinoma after nephrectomy: randomized, double-blind, placebo-controlled phase III study (PROTECT - AN 30/10) to investigate the effectiveness and safety of pazopanib as adjuvant therapy in patients with localized or local advanced renal cell carcinoma after nephrectomy]H Rexer
Der Urologe. Ausg. A|March 23, 2007
[Annual report on study AB25/02-"LEA"]H Rexer
Der Urologe. Ausg. A|June 29, 2007
[New treatment approach to hormone-refractory prostate carcinoma]H Rexer
Der Urologe. Ausg. A|March 29, 2005
[Use of zoledronic acid for high risk prostate cancer patients]H Rexer
Der Urologe. Ausg. A|April 28, 2011
[Study to castrate-resistant prostate cancer: AUO study AP 60/10]H Rexer
Der Urologe. Ausg. A|September 5, 2015
[Study on therapy of metastasized or locally advanced urothelial cancer: A phase III randomized clinical trial of pembrolizumab (MK-3475) versus paclitaxel, docetaxel or vinflunine in subjects with recurrent or progressive metastatic urothelial cancer (Keynote 045) - AP 48/15 der AUO]H Rexer
Der Urologe. Ausg. A|January 28, 2006
[Active studies of the Working Association for Urological Oncology (AUO) in 2006]H Rexer
Der Urologe. Ausg. A|March 19, 2015
[Study on the treatment of nonmuscle invasive bladder cancer: A phase III efficacy study for intravesical instillation of mistletoe extract in superficial bladder cancer (TIM) AB 40/11 of the AUO]H Rexer,
Pageof 11